Recent Posts
- Boehringer Ingelheim and G1 Therapeutics Announce COSELA Now Commercially Available in US
- BridgeBio & Origin BioSciences’ Therapy for Rare Disease
- FDA Clears IND Application for Flexion Therapeutics’ FX301
- FDA Approves Targeted Treatment for Duchenne Muscular Dystrophy
- FDA Partially Rescinds Two Supplemental Biologics License Applications
Topics
- CFDA
- Classification System
- Clinical Trials
- e-Labeling
- e-Learning
- EMA
- Events
- FDA
- Globalization
- Health
- Healthcare
- In-Country Review
- Innovation
- Interpretation
- Language Service Provider
- Linguistic Validation
- Machine Translation
- Medical Translation
- Medical Writing
- Mistranslations
- Mobile Translation
- News
- Pharmaceuticals
- Quality
- Regulatory
- Resources
- Social Media
- Special stories
- Terminology
- Transcreation
- Website Translation